Conditions: Epilepsy
Keywords: Epilepsy partial onset seizure adjunctive therapy
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 210
Healthy volunteers: no

Brief summary:
The purpose of this study is to examine the safety of USL255 as adjunctive therapy in patients with refractory partial onset-seizures.

Detailed description:

Arms:
arm 1: Topiramate extended-release capsules (USL255) up to a maximum of 400 mg per day

Interventions: intervention 1: USL255
Intervention descriptions: intervention 1: None

Protocol document: